Elironrasib + Daraxonrasib

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Elironrasib + Daraxonrasib
Treatment and conditionWhere it standsTrials
Elironrasib + Daraxonrasib for endometrial neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Elironrasib + Daraxonrasib for neoplasm metastasisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1